Wells Fargo Maintains Equal-Weight on LeMaitre Vascular, Raises Price Target to $104
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Wells Fargo analyst Nathan Treybeck maintains LeMaitre Vascular (NASDAQ:LMAT) with a Equal-Weight and raises the price target from $94 to $104.
Wells Fargo analyst Nathan Treybeck maintains LeMaitre Vascular (NASDAQ:LMAT) with a Equal-Weight and raises the price target from $94 to $104.